Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma

被引:23
|
作者
Carneiro Costa, Liana Cristina Melo [1 ]
Leite, Camila Ferreira [1 ]
Cardoso, Sergio Vitorino [2 ]
Loyola, Adriano Mota [2 ]
de Faria, Paulo Rogerio [3 ]
Alencar Souza, Paulo Eduardo [1 ]
Rebello Horta, Martinho Campolina [1 ]
机构
[1] Pontificia Univ Catolica Minas Gerais PUC Minas, Dept Dent, Belo Horizonte, MG, Brazil
[2] Univ Fed Uberlandia, Sch Dent, Lab Oral & Maxillofacial Pathol, BR-38400 Uberlandia, MG, Brazil
[3] Univ Fed Uberlandia, Inst Biomed Sci, BR-38400 Uberlandia, MG, Brazil
关键词
Oral cancer; Squamous cell carcinoma; Cadherins; Vimentin; LYMPH-NODE METASTASIS; E-CADHERIN; POOR-PROGNOSIS; CLINICOPATHOLOGICAL FEATURES; VIMENTIN EXPRESSION; TUMOR PROGRESSION; DOWN-REGULATION; CANCER; ADHESION; CATENIN;
D O I
10.1590/1678-775720140187
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Oral squamous cell carcinoma (OSCC) is one of the most common malignances. In epithelial-mesenchymal transition (EMT), epithelial cells switch to mesenchymal-like cells exhibiting high mobility. This migratory phenotype is significant during tumor invasion and metastasis. Objective: The aim of this study is to evaluate the expression of the EMT markers E-cadherin, N-cadherin and vimentin in OSCC. Material and Methods: Immunohistochemical detection of E-cadherin, N-cadherin and vimentin was performed on 20 OSCC samples. Differences in the expression of each protein at the invasive front (IF) and in the central/superficial areas (CSA) of the tumor were assessed. Differences in the expression of each protein at the IF of both histologically high-and low-invasive OSCCs were evaluated. Associations among expression of proteins at the IF were assessed. Correlations between the expression levels of each protein at the IF and the tumor stage and clinical nodal status were also evaluated. Results: Reduced expression of E-cadherin was detected in 15 samples (75%). E-cadherin expression was reduced at the IF when compared to the CSA and in high-invasive tumors when compared to low-invasive tumors. All samples were negative for N-cadherin, even though one sample showed an inconspicuous expression. Positive expression of vimentin was observed in 6 samples (30%). Nevertheless, there was no difference in vimentin expression between the IF and the CSA regions or between the low-and high-invasive tumors. Furthermore, no association was observed among protein expression levels at the IF. Finally, no correlations were observed between each protein's expression levels and tumor stage or clinical nodal status. Conclusions: Reduced E-cadherin expression at the IF and its association with histological invasiveness suggest that this protein is a noteworthy EMT marker in OSCC. Although vimentin was also detected as an EMT marker, its expression was neither limited to the IF nor was it related to histological invasiveness.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 50 条
  • [21] Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma
    Iwata, Eiji
    Hasegawa, Takumi
    Takeda, Daisuke
    Ueha, Takeshi
    Kawamoto, Teruya
    Akisue, Toshihiro
    Sakai, Yoshitada
    Komori, Takahide
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (04) : 1493 - 1498
  • [22] Epithelial-mesenchymal transition in osteogenic sarcoma of the neck following oral squamous cell carcinoma
    Kim, Hyun Sil
    Kim, Nam Hee
    Han, Seon Hui
    Cha, In Ho
    Seo, Dong Jun
    Park, Wonse
    Yook, Jong In
    Kim, Hyung Jun
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2010, 36 (03) : 172 - 176
  • [23] Immunodetection of Epithelial-Mesenchymal Transition and Tumor Proliferation Markers in GLi-1-positive Oral Squamous Cell Carcinoma
    Dantas, Rebeca C. M.
    Guimaraes, Vanessa S. N.
    de Souza, Renata O.
    Valverde, Ludmila F.
    Vidal, Manuela T. A.
    Nogueira, Raphael L. R.
    da Rocha, Leonardo O. S.
    Araujo, Giovana T.
    Dos Santos, Jean N.
    Rocha, Clarissa A. G.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (05) : 335 - 344
  • [24] Spindle cell squamous cell carcinoma showing epithelial-mesenchymal transition
    Iwata, H.
    Aoyama, Y.
    Kamiya, H.
    Ichiki, Y.
    Kitajima, Y.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (02) : 214 - 215
  • [25] The expression of epithelial-mesenchymal transition and cancer stem cell markers in oral dysplasia and cancer
    Eiultekin, S. K.
    Yucel, O. Ozer
    Senguven, B.
    Arslan, L.
    VIRCHOWS ARCHIV, 2016, 469 : S121 - S121
  • [26] Relationship between TWIST expression and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma
    Gao, Yuan
    Xuan, Xiao-Yan
    Zhang, Hong-Yan
    Wang, Feng
    Zeng, Qing-Ru
    Wang, Zhi-Qiang
    Li, Shan-Shan
    CELL BIOLOGY INTERNATIONAL, 2012, 36 (06) : 571 - 577
  • [27] Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung
    Kim, Seok-Hyung
    Kim, Jin Man
    Shin, Myeong-hee
    Kim, Chul Woung
    Huang, Song-Mei
    Kang, Dong Wook
    Suh, Kwang Sun
    Yi, Eunhee S.
    Kim, Kyung-Hee
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (05) : 581 - 591
  • [28] Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma
    Tsutsumi, Satoshi
    Saeki, Hiroshi
    Nakashima, Yuichiro
    Ito, Shuhei
    Oki, Eiji
    Morita, Masaru
    Oda, Yoshinao
    Okano, Shinji
    Maehara, Yoshihiko
    CANCER SCIENCE, 2017, 108 (06): : 1119 - 1127
  • [29] Carbonic Anhydrase III Promotes Cell Migration and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
    Chu, Yin-Hung
    Su, Chun-Wen
    Hsieh, Yih-Shou
    Chen, Pei-Ni
    Lin, Chiao-Wen
    Yang, Shun-Fa
    CELLS, 2020, 9 (03)
  • [30] Epithelial-mesenchymal transition and cancer stem cells: Missing link in oral squamous cell carcinoma
    Jayaraman, S.
    Pazhani, J.
    Veeraraghavan, V. P.
    Shankargouda, P.
    ANNALS OF ONCOLOGY, 2022, 33 : S1525 - S1525